Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer

BACKGROUND: Despite optimal surgical treatment and modern adjuvant therapies, 50% of patients diagnosed with colorectal cancer die within 5 years. Immunotherapy offers an appealing complement to traditional chemotherapy, with possible long-term protection against tumor recurrences through immunologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Mona, Marits, Per, Dahl, Kjell, Dagöö, Tobias, Enerbäck, Sven, Thörn, Magnus, Winqvist, Ola
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Colorectal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889279/
https://www.ncbi.nlm.nih.gov/pubmed/20119674
http://dx.doi.org/10.1245/s10434-010-0920-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889279/
https://www.ncbi.nlm.nih.gov/pubmed/20119674
http://dx.doi.org/10.1245/s10434-010-0920-8

Ejemplares similares